drug

bosutinib

1 story · latest Nov 6, 2026

Follow bosutinib. Every new filing, FDA action, and trial change, in your feed and a morning email, each linked to its source.

Follow free for 14 daysNo card.

Status: FDA approved Sep 2012 · NDA203341, NDA217729
Brand: Bosulif
Trials: 5 registered trials in coverage

Relationships

Developed by Pfizer

Timeline

Enliven sticks to year-end ENABLE-2 start after FDA alignment on CML trial design

Nov 6Regulatory decisionEnliven TherapeuticsUpdated

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.